Astrana Health Net Worth
Astrana Health Net Worth Breakdown | ASTH |
Astrana Health Net Worth Analysis
Astrana Health's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Astrana Health's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Astrana Health's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Astrana Health's net worth analysis. One common approach is to calculate Astrana Health's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Astrana Health's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Astrana Health's net worth. This approach calculates the present value of Astrana Health's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Astrana Health's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Astrana Health's net worth. This involves comparing Astrana Health's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Astrana Health's net worth relative to its peers.
Enterprise Value |
|
To determine if Astrana Health is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Astrana Health's net worth research are outlined below:
| Astrana Health generated a negative expected return over the last 90 days | |
| Astrana Health has high historical volatility and very poor performance | |
| Astrana Health is unlikely to experience financial distress in the next 2 years | |
| Astrana Health was previously known as Astrana Health and was traded on NASDAQ Exchange under the symbol AMEH. | |
| About 24.0% of the company shares are held by company insiders | |
| Latest headline from simplywall.st: Impressive Earnings May Not Tell The Whole Story For Astrana Health |
Know Astrana Health's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Astrana Health is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Astrana Health backward and forwards among themselves. Astrana Health's institutional investor refers to the entity that pools money to purchase Astrana Health's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Northern Trust Corp | 2024-09-30 | 424.1 K | Morgan Stanley - Brokerage Accounts | 2024-09-30 | 342.6 K | Fort Washington Investment Advisors Inc | 2024-09-30 | 299.8 K | Bank Of New York Mellon Corp | 2024-09-30 | 268.7 K | Goldman Sachs Group Inc | 2024-09-30 | 258.9 K | Royal Bank Of Canada | 2024-09-30 | 254.6 K | Bellevue Group Ag | 2024-09-30 | 254.2 K | Amvescap Plc. | 2024-09-30 | 241.8 K | Atria Wealth Solutions, Inc. | 2024-09-30 | 237.4 K | Blackrock Inc | 2024-06-30 | 6.4 M | Vanguard Group Inc | 2024-09-30 | 4.7 M |
Follow Astrana Health's market capitalization trends
The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.97 B.Market Cap |
|
Project Astrana Health's profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | 0.10 | 0.11 | |
| Return On Capital Employed | 0.12 | 0.12 | |
| Return On Assets | 0.07 | 0.07 | |
| Return On Equity | 0.10 | 0.10 |
When accessing Astrana Health's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures Astrana Health's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Astrana Health's profitability and make more informed investment decisions.
Evaluate Astrana Health's management efficiency
Astrana Health has return on total asset (ROA) of 0.0449 % which means that it generated a profit of $0.0449 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.1026 %, meaning that it created $0.1026 on every $100 dollars invested by stockholders. Astrana Health's management efficiency ratios could be used to measure how well Astrana Health manages its routine affairs as well as how well it operates its assets and liabilities. The Astrana Health's current Return On Tangible Assets is estimated to increase to 0.11. The Astrana Health's current Return On Capital Employed is estimated to increase to 0.12. As of now, Astrana Health's Non Currrent Assets Other are increasing as compared to previous years. The Astrana Health's current Other Current Assets is estimated to increase to about 18.3 M, while Other Assets are projected to decrease to under 12.9 M.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 8.79 | 8.26 | |
| Tangible Book Value Per Share | 1.29 | 1.23 | |
| Enterprise Value Over EBITDA | 14.86 | 8.74 | |
| Price Book Value Ratio | 2.95 | 4.22 | |
| Enterprise Value Multiple | 14.86 | 8.74 | |
| Price Fair Value | 2.95 | 4.22 | |
| Enterprise Value | 1.8 B | 1 B |
Understanding the operational decisions made by Astrana Health management offers insights into its financial robustness. This evaluation is crucial for assessing the stock's investment potential.
Enterprise Value Revenue 1.2193 | Revenue 1.7 B | Quarterly Revenue Growth 0.375 | Revenue Per Share 36.415 | Return On Equity 0.1026 |
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Astrana Health insiders, such as employees or executives, is commonly permitted as long as it does not rely on Astrana Health's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Astrana Health insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Astrana Health Corporate Filings
F4 | 26th of November 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
8K | 14th of November 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
10Q | 12th of November 2024 Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations | ViewVerify |
| 15th of July 2024 Other Reports | ViewVerify |
Astrana Health Earnings per Share Projection vs Actual
Astrana Health Corporate Management
| WaiChow MD | Chief Officer | Profile | |
| Rita Pew | Vice Operations | Profile | |
| Carlos MD | Chief Texas | Profile | |
| CPA CGMA | Chief Officer | Profile |
Already Invested in Astrana Health?
The danger of trading Astrana Health is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Astrana Health is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Astrana Health. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Astrana Health is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Astrana Health offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Astrana Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Astrana Health Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Astrana Health Stock: Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Astrana Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. For more detail on how to invest in Astrana Stock please use our How to Invest in Astrana Health guide.You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Astrana Health. If investors know Astrana will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Astrana Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.30) | Earnings Share 1.3 | Revenue Per Share 36.415 | Quarterly Revenue Growth 0.375 | Return On Assets 0.0449 |
The market value of Astrana Health is measured differently than its book value, which is the value of Astrana that is recorded on the company's balance sheet. Investors also form their own opinion of Astrana Health's value that differs from its market value or its book value, called intrinsic value, which is Astrana Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Astrana Health's market value can be influenced by many factors that don't directly affect Astrana Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Astrana Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Astrana Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Astrana Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.